HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine → HCID 10137646, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | HCID 10180885 | HCID 10180885 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | N-methyl-2-pyrrolidone | HCID 13387 | — |
| Product | HCID 10137646 | HCID 10137646 | — |
| Product | HCID 21903395 | HCID 21903395 | — |
Reaction Steps
To a solution of 5-bromo-N-(3,5-dichlorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide from Example 50 (25 mg, 0.060 mmol), piperazine (30.25 mg, 0.35 mmol) in 1-methylpyrrolidinone (0.25 ml) was heated at 135 C for 18 hrs. The resulting mixture was further diluted with DMF (0.25 ml) and TFA (50 ul) and purified by preparative HPLC (Gilson Semi Preparative HPLC System and a YMC Combiprep Pro Column (50×20 mm i.d., C18, S-5 um, 120A) eluting with 5-95% acetonitrile/water (0.1%) at 15 ml/min) to afford the title compound as the piperazin-4-ium trifluoroacetate salt after lyophillization.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06921759B2 |
| Source dataset | uspto-grants-2005_07 |
| ORD ID | ord-c0f7b38bb472415098d3ddfca6b20188 |
| Source note | uspto-grants-2005_07 |